Hypoxic/ischemic brain injury in the neonate can activate an inflammatory cascade, which potentiates cellular injury. The role of microglia in this inflammatory response has not been studied extensively. We used an in vitro model of murine microglia to investigate changes in microglial cytokine release and injury during early development. Isolated microglia were subjected to lipopolysaccharide (LPS) activation or injury by glucose deprivation (GD), serum deprivation (SD), or combined oxygenglucose deprivation (OGD) for varying durations. The extent and the type of cell death were determined by trypan blue, terminal deoxynucleotidyl end-nick labeling, and annexin staining. Earlyculture microglia (2-3 d in purified culture) showed significantly more apoptotic cell death after SD, GD, and OGD compared with microglia maintained in culture for 14 -17 d. Measurements of tumor necrosis factor-␣ (TNF-␣) and IL-1␤ in culture media demonstrated that OGD induced greater release of both TNF-␣ and IL-1␤ than LPS activation, with early-culture microglia producing more TNF-␣ compared with late-culture microglia.
Neonatal hypoxic/ischemic brain injury causes significant long-term neurologic morbidity in survivors. Deleterious outcomes include cerebral palsy, mental retardation, and cognitive and behavioral dysfunction. Hypoxia and ischemia can occur with birth asphyxia or prenatally with chronic placental vascular insufficiency and fluctuations in cerebral blood flow. Another factor that contributes to brain injury is infection and inflammation. Maternal chorioamnionitis, whether acute or subclinical, has been associated with a 9-fold increased risk for cerebral palsy (1) .
Recently, the contribution of inflammation to hypoxic/ ischemic brain injury has been recognized. Microglia, or resident brain macrophages, are the major inflammatory cell type in the CNS. Upon activation, they release proinflammatory cytokines, oxygen free radicals, and nitric oxide and can stimulate astrocytes to do the same (2, 3) . The release of cytokines from activated microglia may further exacerbate neuronal injury, whereas inhibition of tumor necrosis factor-␣ (TNF-␣) reduces neuronal death in vitro and in vivo (4, 5) . The potentiation of hypoxic/ischemic injury by inflammation is a significant therapeutic target in adult cerebral ischemia (6, 7) that has not been studied extensively in the perinatal setting.
Sensitivity to hypoxic/ischemic injury is known to change with development. Data from the National Collaborative Perinatal Project showed that periventricular leukomalacia peaked and fluorescein tagged 2'-deoxyuridine 5'-triphosphate for 1 h at 37°C, followed by reaction with horseradish peroxidase-conjugated anti-fluorescein antibody for 30 min to amplify the signal. DNAse (Invitrogen, Carlsbad, CA) was added to some cultures before staining as a positive control. Other positive controls were neuronal cultures deprived of serum for 24 h. Labeling was visualized using diaminobenzidine (Sigma Chemical Co.), and cells were counted using bright field microscopy (ϫ40). Criteria for TUNEL-positive cells were intense staining coupled with fragmented or condensed and shrunken nuclei.
Annexin V staining of injured cells was performed after PBS wash by incubation for 15 min with Annexin V FITC reagent mixture and propidium iodide (PI) according to manufacturer's recommendations (Santa Cruz Biotechnology, Santa Cruz, CA). Labeled cells then were analyzed by fluorescence microscope and counted. Cells were considered apoptotic when they stained for annexin but not PI. Annexin-positive cells that were also PI staining could be either apoptotic or necrotic with access to phosphatidylserine on the inner leaflet of the membrane occurring as a result of breakdown of the plasma membrane. To avoid this possible confound, cultures were stained early after injury and analyzed before Ͼ5% of the cells stained with PI. Serum-deprived young neurons were used as a positive apoptotic control; healthy cells were used as a negative control.
Activated caspase-3 was assessed by immunohistochemistry as a biochemical marker of apoptosis. Cells were fixed with 50% acetone/50% methanol, incubated with 0.3% hydrogen peroxide to block endogenous peroxidases, and blocked with 2% goat serum to prevent nonspecific binding. Cells then were incubated with anti-active caspase-3 primary antibody at 1:1000 dilution (rabbit monoclonal; Pharmingen, San Diego, CA). Secondary antibody conjugated to horseradish peroxidase then was added. Neurons that were treated with serum deprivation for 24 h again were used as a positive control, and healthy cells were used as a negative control. Cells were exposed to 0.2 mL of diaminobenzidine substrate and counted under bright field microscopy (ϫ40 objective) in four fields per well. Approximately 100 cells per well were counted.
LPS activation. Microglia were exposed to lipopolysaccharide (LPS; Escherichia coli serotype O55:B5; Sigma Chemical Co.) at a concentration of 10 g/mL. This concentration was previously shown to activate murine microglia without causing cell death (14) . Microglia that were cultured for 3 or 14 d were incubated for 24 h with LPS at 37°C in 5% serum growth media.
Cytokine assays. Culture supernatants after OGD injury or LPS activation were collected and saved at Ϫ80°C until assayed. ELISA assays for TNF-␣ and IL-1B were run according to the manufacturer's instructions (BD Bioscience, San Diego, CA). Culture medium was added to 96-well plates followed by coating antibodies. TNF-␣ and IL-1␤ standards, blanks, and experimental conditions were run in parallel, in triplicate. Biotin-conjugated detection antibody was added and visualized by 3,3'5,5'-tetramethylbenzidine. Stop solution was added after 30 min. Absorbance at 450 nm was measured on a SpectraMAX 340 plate reader (Molecular Devices, Sunnyvale, CA). Measurements were normalized to the amount of protein per well. Protein concentrations were determined using the bicinchoninic acid method (BCA protein assay; Bio-Rad, Hercules, CA).
Statistics. All data were analyzed and statistical significance was determined with t test or ANOVA and Student Newman-Keuls test for multiple comparisons (SigmaStat; SPSS Science, Chicago, IL). A p Ͻ 0.05 was considered significant.
Type of cell death. To ascertain the type of cell death that occurs in microglia as a function of duration in culture, we used several assays for apoptosis. Nuclear morphology was observed after Hoechst and PI staining. Control microglia stained with Hoechst dye had discrete, round nuclei (Fig. 4A ). After SD, GD, and OGD, nuclei of nonviable microglia stained with PI. Many nuclei were small, and characteristic apoptotic nuclear fragmentation was occasionally observed (Fig. 4B) . TUNEL staining showed that the majority of early-culture microglia (DIV 3) were TUNEL positive with condensed nuclei after all three insults tested (Fig. 4C) . Staining with annexin demonstrated that all injuries resulted in externalization of phosphatidylserine to the outer leaflet of the plasma membrane before membrane breakdown, an early sign of apoptosis (17) (Fig. 4D) .
We also assayed for activated caspase-3, a known execution protease in apoptosis. Compared with control cultures, both early-and late-culture microglia (DIV 2 and DIV 14) were positive for activated caspase-3 after 24 h of OGD. There was no significant difference between early and late cultures in the number of caspase-3-positive cells after 24 h of OGD, an insult resulting in equivalent cell death (Fig. 5) .
Cytokine release. To look for possible changes in inflammatory response of microglia with age, we measured cytokine release after OGD to correlate with age-related changes in microglial survival. Early-culture microglia (DIV 3) released more than twice as much TNF-␣ compared with late-culture microglia (DIV 14) after both 8 and 18 h of OGD. TNF-␣ release increased with longer durations of OGD, and the difference between early and late cultures was more pronounced after 18 h of OGD (Fig. 6A ). There was a 10-fold increase in IL-1␤ levels after OGD, but no significant difference in the release of IL-1␤ between early-and late-culture microglia was observed after injury (Table 1) .
We also measured cytokine release after an inflammatory stimulus, exposure to LPS. Early-culture, LPS-stimulated microglia (DIV 3) released more than twice as much TNF-␣ 
DEVELOPMENT AND MICROGLIAL APOPTOSIS
(3909 pcg/mcg protein) as late-culture (DIV 14) microglia (1856 pcg/mcg protein; p Ͻ 0.05; Fig. 6B ). There was a 2-fold increase in IL-1␤ levels after LPS addition but no significant difference with age in culture ( Table 1) . LPS addition did not cause significant microglial cell death at either age in culture through 24 h.
DISCUSSION
The importance of microglia and inflammation in brain injury is widely recognized. However, very little research has been done on the effects of development on microglial function. Our results show that early-culture microglia are more vulnerable to stresses that simulate ischemia as well as to induction of apoptosis by loss of growth factors (SD). This decrease in vulnerability to injury with age in culture is similar to the response of oligodendrocytes (9) and contrasts with findings for neurons and astrocytes (18, 19) .
The selective vulnerability of early-culture microglia may be due to immaturity of mechanisms that normally protect against stress. For example, impaired glucose and substrate utilization in the immature brain can further worsen hypoxic/ischemic injury in rats (20) . Specifically relevant to activated microglia is their ability to manage oxidative stress given their innate production of nitric oxide and superoxide (21) . It is possible that lower antioxidant levels in young microglia impair their ability to combat oxidative stress. Although specific changes in microglial antioxidant levels with age have yet to be described, it is known that several antioxidant enzymes overall are lower in immature neonatal rat brain than in adult brain (22, 23) . Decreased glutathione stores and increased free iron in immature brain can also result in more free radical generation (24) . This susceptibility to oxidative injury may also characterize developing microglia.
The mode of cell death was primarily apoptosis in both early-and late-culture microglia. The cultures demonstrated morphologic features consistent with apoptosis, including nuclear condensation and DNA fragmentation (by Hoechst/PI and TUNEL staining). Caspase-3 activation and externalization of phosphatidylserine residues before cell lysis were observed, also consistent with apoptosis. There was no significant difference in the extent of apoptosis with the type of injury or age of microglia in culture.
Microglial activation can lead to release of factors that contribute to neurotoxicity (25) (26) (27) (28) , a process that may be influenced by age. Therefore, we tested whether the inflammatory response mounted by microglia changed with time in our cultures. Baseline release of TNF-␣ or IL-1␤ did not vary with age. Both OGD and LPS markedly induced release of both cytokines. Whereas early-culture microglia exhibited increased TNF-␣ release compared with late-culture microglia, induced IL-1␤ release did not vary with the age of the cultures. Both cytokines are up-regulated in response to ischemic brain injury (29) . The differential effect observed here for the two cytokines is consistent with evidence for differential regulation of IL-1␤ and TNF-␣ by the MEK1/2 mediated signaling pathways (30) .
Our finding that microglial death is largely apoptotic is consistent with other in vitro studies showing apoptosis in young cultured microglia after LPS overactivation, interferon-␥ exposure, and opiate administration (31) (32) (33) . Chromatin condensation was previously described in serum-deprived cultured microglia with comparable levels of cell death to our findings (34) . In contrast, few studies have been done on injury-induced release of cytokines by developing microglia. One study (35) found that LPS induced greater IL-6 and IL-1 release with age in microglia and no age-related change in TNF-␣. However, this study was done in microglia that were cultured from 3-and 24-mo-old rats compared with our neonatal mouse model. Chemokine expression by microglia after hypoxic/ischemic injury showed similar developmental regu- CHOCK AND GIFFARD lation to our findings in a study describing disappearance of MIP-1␣ from rat microglia between P7 and P12 (36) . A number of inflammatory mediators that are released by microglia, including cytokines and nitric oxide, not only affect other cells but also may themselves feedback on microglia. It is possible that the increased TNF-␣ released by our earlyculture microglia contributed to their tendency to undergo apoptosis after injury. One study found that TNF-␣ increased the susceptibility of microglia to Fas-ligand-induced apoptosis and was associated with down-regulation of the antiapoptotic genes Bcl-2 and Bcl-x L (37). However, another study implicated microglial production of nitric oxide as the primary autocrine mediator of microglial apoptosis (31) . These authors found that inhibition of TNF-␣ did not affect apoptosis. Regardless of the mechanism, autoregulatory apoptosis to prevent overactivation of microglia may play a role during development of the CNS.
In vivo studies are less clear about the extent of microglial apoptotic cell death after injury. Neonatal piglets that are subjected to hypoxia/ischemia show exclusively apoptotic cell death in immature cerebral white matter (38) . Neonatal rats after focal ischemia also demonstrate microglia with DNA fragmentation and expression of the proapoptotic gene Bax (39) . In contrast, a study of developing embryonic rat brain found that apoptotic microglia constituted only a very small fraction of the entire microglial cell population until postnatal day 18. The authors postulated that apoptosis does not play a major role in regulating microglial density during development (40) . However, with injury, apoptosis may be the primary mechanism of cell death. To the extent that our injury paradigms mimic insults that may occur in the perinatal period, our data support the idea that apoptosis is the predominant pathway for microglial death in the perinatal period.
Several studies demonstrate decreases in caspase 3 levels with development. Murine caspase 3 mRNA and protein levels markedly declined from postnatal day 12 onward (41, 42) . Similarly, after hypoxic/ischemic injury, levels of caspase 3 declined from postnatal days 7 to 15 in rats (43) with greater necrotic neuronal morphology in older rats compared with a combination of necrotic and apoptotic morphology in immature rats (44) . Previous in vitro studies by us and others using whole brain extracts and isolated neuronal cells also found decreased caspase 3 levels with age in culture and after injury (19, 45) . None of these studies looked specifically at levels of caspase 3 in microglia with development. Our present in vitro measurements did not show a significant change in the percentage of activated caspase 3-positive cells between DIV 2 and DIV 14, in contrast to findings in other cell types with development. We did observe more rapid cell death in early cultures. The lack of a significant difference in apoptotic versus necrotic morphology, percentage of TUNEL-positive cells, and percentage of annexin-positive cells between early and late cultures suggests that the more rapid cell death in early cultures is unlikely to represent a greater component of necrotic cell death.
Human studies also support developmental changes in cytokine production. Some premature infants who were Ͻ28 wk gestation had very high serum levels of proinflammatory cytokines, including TNF-␣, IL-1, and IL-6, which then declined during the first postnatal week (46) . Underlying inflammatory changes associated with preterm delivery may account for an initial peak in cytokine levels. Neonatal brains with periventricular leukomalacia similarly exhibited high expression of TNF-␣ and to a lesser extent IL-1␤ (47) . The pattern of cytokine expression in anoxic brains without periventricular leukomalacia also showed significantly lower TNF-␣ immunoreactivity. Therefore, TNF-␣ may be an important mediator involved in the pathogenesis of periventricular leukomalacia. It is interesting that in our study, TNF-␣ was released at higher levels from immature microglia, a factor that might contribute to the propensity for periventricular leukomalacia injury to occur in premature infants.
Our conclusions should be interpreted in the context of a cell culture environment. Longer times in culture may in some respects parallel in vivo changes seen with development, but validation of this possibility must await the identification of markers that change with microglial development. We are not aware of any cellular markers that have been documented to change expression markedly with postnatal development in microglia. Our research suggests that developmental changes do occur in microglia, as has been documented for other brain cell types. Compared with astrocytes and neurons, microglia require a longer duration of injury to achieve the same amount of cell death in young cultures (48) . Additional in vivo studies are needed to delineate the importance of apoptotic pathways in microglia with development.
This research explores the response of neonatal microglia to both inflammatory and ischemia-like stimuli as they age in culture. Early-culture microglia are more vulnerable to apoptosis after various insults (SD, GD, and OGD). They also exhibit increased cytokine release that can potentiate ischemic brain injury. Further research on inflammatory changes with development will lead to a better understanding of the role of microglia in perinatal brain injury.
